Trial intelligence / Profile preview

Effect of Urine Acid-base Disequilibrium on Captopril PK

NCT06292091Phase 1Completed

Sponsor
Seoul National University Hospital
Start
Feb 2024
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of captopril in hypertension (HTN) (3 arms), sponsored by Seoul National University Hospital. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration and Maximum Plasma Concentration. Started Feb 2024; status: completed.

02

Drugs

captopril
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT06292091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06292091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call